• 600 Citations
  • 8 h-Index
20042019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Wei Luo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Radiotherapy Medicine & Life Sciences
Intensity-Modulated Radiotherapy Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Chemoradiotherapy Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
Induction Chemotherapy Medicine & Life Sciences
Conformal Radiotherapy Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

  • 600 Citations
  • 8 h-Index
  • 30 Article
  • 1 Comment/debate
  • 1 Review article
1 Citation (Scopus)

Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: A propensity score-matched analysis

Liao, J. F., Zhang, Q., Du, X. J., Lan, M., Liu, S., Xia, Y. F., Cai, X. Y. & Luo, W., Jun 27 2019, In : Cancer Communications. 39, 1, 40.

Research output: Contribution to journalArticle

Open Access
docetaxel
Propensity Score
Chemoradiotherapy
Cisplatin
Survival
Open Access
docetaxel
Propensity Score
Chemoradiotherapy
Cisplatin
Cancer Care Facilities

Long-Term survival and prognostic factors in locoregionally advanced nasopharyngeal carcinoma patients treated with TPF induction chemotherapy followed by cisplatin-combined concurrent chemoradiotherapy

Zhang, Q., Wang, Y., Liao, J. F., Ren, Y. F., Shen, G. P., Niu, S. Q. & Luo, W., Jan 1 2019, In : Journal of Cancer. 10, 17, p. 3899-3907 9 p.

Research output: Contribution to journalArticle

Open Access
Induction Chemotherapy
Chemoradiotherapy
Cisplatin
Survival
docetaxel
2 Citations (Scopus)

A comparison of weekly versus 3-weekly cisplatin during concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma using intensity modulated radiation therapy: A matched study

Meng, D. F., Sun, R., Peng, L. X., Huang, Y. S., Yang, Q., Luo, D. H., Hu, W. H., Xie, F. Y., Luo, W., Zhao, C., Guo, L., Mai, H. Q., Chen, M. Y., Xie, P., Zheng, L. S., Yang, J. P., Mei, Y., Qiang, Y. Y., Xu, L., Li, C. Z. & 3 others, Huang, B. J., Qian, C. N. & Sun, R., Jan 1 2018, In : Journal of Cancer. 9, 1, p. 92-99 8 p.

Research output: Contribution to journalArticle

Chemoradiotherapy
Cisplatin
Radiotherapy
Intensity-Modulated Radiotherapy
Survival
22 Citations (Scopus)

MicroRNAs and cancer: Key paradigms in molecular therapy (Review)

Tan, W., Liu, B., Qu, S., Liang, G., Luo, W. & Gong, C., Mar 2018, In : Oncology Letters. 15, 3, p. 2735-2742 8 p.

Research output: Contribution to journalReview article

MicroRNAs
Neoplasms
Therapeutics
Small Untranslated RNA
Liver Neoplasms